Results 1 to 10 of about 14,319 (252)

Error in Figure 2.

JAMA Ophthalmol
europepmc   +1 more source

Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists. [PDF]

Vision (Basel)
Lixi F, Troisi M, Calabresi V, Giagoni A, Rossi C, Timofte-Zorila MM, Tarași TC, Vitiello L, Tomi MI, Gheorghe AG, Coco G, Lanzolla G, Giannaccare G.   +12 more
europepmc   +1 more source

Exploring the Potential Link Between Tirzepatide and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): Evidence from FAERS and Google Trends. [PDF]

Hosp Pharm
Castellana E, Chiappetta MR.
europepmc   +1 more source

High-resolution MRI features of nonarteritic anterior ischemic optic neuropathy: a case series. [PDF]

Int J Ophthalmol
Lee BE, Yoon RG.
europepmc   +1 more source

Anterior Ischemic Optic Neuropathy as a Paraneoplastic Manifestation of Colorectal Cancer. [PDF]

Cureus
Ferreira Sacramento G, Brito S, Mesquita T.   +2 more
europepmc   +1 more source

Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies. [PDF]

PLoS Med
Chrzanowski J, Walicka M, Burzyński J, Zaraś M, Michalak A, Fendler W.   +5 more
europepmc   +1 more source

GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy.

JAMA Netw Open
Choi T, Al-Aly Z, Xie Y.
europepmc   +1 more source

Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis. [PDF]

AACE Endocrinol Diabetes
Eisa N, Barood O.
europepmc   +1 more source

Posterior ischemic optic neuropathy as the main manifestation of giant cell arteritis: a case-based literature review. [PDF]

Reumatologia
Barankiewicz-Tyc N, Wąsik N, Majewski P, Kania K, Moskal J, Kalinowska A.   +5 more
europepmc   +1 more source